PHYSIOLOGY.ORG
Skip main navigation
Close Drawer MenuOpen Drawer Menu
Research ArticleRenal Mechanisms of Tissue Remodeling

Biphasic MIF and SDF1 expression during podocyte injury promote CD44-mediated glomerular parietal cell migration in focal segmental glomerulosclerosis

Published Online:02 Mar 2020https://doi.org/10.1152/ajprenal.00414.2019

Abstract

Glomerular parietal epithelial cell (PEC) activation, as revealed by de novo expression of CD44 and cell migration toward the injured filtration barrier, is a hallmark of podocyte injury-driven focal segmental glomerulosclerosis (FSGS). However, the signaling pathway that mediates activation of PECs in response to podocyte injury is unknown. The present study focused on CD44 signaling, particularly the roles of two CD44-related chemokines, migration inhibitory factor (MIF) and stromal cell-derived factor 1 (SDF1), and their common receptor, chemokine (C-X-C motif) receptor 4 (CXCR4), in the NEP25/LMB2 mouse podocyte-toxin model of FSGS. In the early phase of the disease, CD44-positive PECs were locally evident on the opposite side of the intact glomerular tuft and subsequently increased in the vicinity of synechiae with podocyte loss. Expression of MIF and SDF1 was first increased in injured podocytes and subsequently transferred to activated PECs expressing CD44 and CXCR4. In an immortalized mouse PEC (mPEC) line, recombinant MIF and SDF1 (rMIF and rSDF1, respectively) individually increased CD44 and CXCR4 mRNA and protein levels. rMIF and rSDF1 stimulated endogenous MIF and SDF1 production. rMIF- and rSDF1-induced mPEC migration was suppressed by CD44 siRNA. However, MIF and SDF1 inhibitors failed to show any impact on proteinuria, podocyte number, and CD44 expression in NEP25/LMB2 mice. Our data suggest that injured podocytes upregulate MIF and SDF1 that stimulate CD44 expression and CD44-mediated migration, which is enhanced by endogenous MIF and SDF1 in PECs. This biphasic expression pattern of the chemokine-CD44 axis in podocytes and PECs may be a novel mechanism of “podocyte-PEC cross-talk” signaling underlying podocyte injury-driven FSGS.

REFERENCES

  • 1. Al-Abed Y, Dabideen D, Aljabari B, Valster A, Messmer D, Ochani M, Tanovic M, Ochani K, Bacher M, Nicoletti F, Metz C, Pavlov VA, Miller EJ, Tracey KJ. ISO-1 binding to the tautomerase active site of MIF inhibits its pro-inflammatory activity and increases survival in severe sepsis. J Biol Chem 280: 36541–36544, 2005. doi:10.1074/jbc.C500243200.
    Crossref | PubMed | ISI | Google Scholar
  • 2. Bruchfeld A, Wendt M, Miller EJ. Macrophage migration inhibitory factor in clinical kidney disease. Front Immunol 7: 8, 2016. doi:10.3389/fimmu.2016.00008.
    Crossref | PubMed | ISI | Google Scholar
  • 3. Chen L, Al-Awqati Q. Segmental expression of Notch and Hairy genes in nephrogenesis. Am J Physiol Renal Physiol 288: F939–F952, 2005. doi:10.1152/ajprenal.00369.2004.
    Link | ISI | Google Scholar
  • 4. Cichy J, Puré E. The liberation of CD44. J Cell Biol 161: 839–843, 2003. doi:10.1083/jcb.200302098.
    Crossref | PubMed | ISI | Google Scholar
  • 5. D’Agati VD, Kaskel FJ, Falk RJ. Focal segmental glomerulosclerosis. N Engl J Med 365: 2398–2411, 2011. doi:10.1056/NEJMra1106556.
    Crossref | PubMed | ISI | Google Scholar
  • 6. Dijkman H, Smeets B, van der Laak J, Steenbergen E, Wetzels J. The parietal epithelial cell is crucially involved in human idiopathic focal segmental glomerulosclerosis. Kidney Int 68: 1562–1572, 2005. doi:10.1111/j.1523-1755.2005.00568.x.
    Crossref | PubMed | ISI | Google Scholar
  • 7. Djudjaj S, Lue H, Rong S, Papasotiriou M, Klinkhammer BM, Zok S, Klaener O, Braun GS, Lindenmeyer MT, Cohen CD, Bucala R, Tittel AP, Kurts C, Moeller MJ, Floege J, Ostendorf T, Bernhagen J, Boor P. Macrophage migration inhibitory factor mediates proliferative GN via CD74. J Am Soc Nephrol 27: 1650–1664, 2016. doi:10.1681/ASN.2015020149.
    Crossref | PubMed | ISI | Google Scholar
  • 8. Donzella GA, Schols D, Lin SW, Esté JA, Nagashima KA, Maddon PJ, Allaway GP, Sakmar TP, Henson G, De Clercq E, Moore JP. AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor. Nat Med 4: 72–77, 1998. doi:10.1038/nm0198-072.
    Crossref | PubMed | ISI | Google Scholar
  • 9. Eng DG, Sunseri MW, Kaverina NV, Roeder SS, Pippin JW, Shankland SJ. Glomerular parietal epithelial cells contribute to adult podocyte regeneration in experimental focal segmental glomerulosclerosis. Kidney Int 88: 999–1012, 2015. doi:10.1038/ki.2015.152.
    Crossref | PubMed | ISI | Google Scholar
  • 10. Eremina V, Jefferson JA, Kowalewska J, Hochster H, Haas M, Weisstuch J, Richardson C, Kopp JB, Kabir MG, Backx PH, Gerber HP, Ferrara N, Barisoni L, Alpers CE, Quaggin SE. VEGF inhibition and renal thrombotic microangiopathy. N Engl J Med 358: 1129–1136, 2008. doi:10.1056/NEJMoa0707330.
    Crossref | PubMed | ISI | Google Scholar
  • 11. Eymael J, Sharma S, Loeven MA, Wetzels JF, Mooren F, Florquin S, Deegens JK, Willemsen BK, Sharma V, van Kuppevelt TH, Bakker MA, Ostendorf T, Moeller MJ, Dijkman HB, Smeets B, van der Vlag J. CD44 is required for the pathogenesis of experimental crescentic glomerulonephritis and collapsing focal segmental glomerulosclerosis. Kidney Int 93: 626–642, 2018. doi:10.1016/j.kint.2017.09.020.
    Crossref | PubMed | ISI | Google Scholar
  • 12. Fatima H, Moeller MJ, Smeets B, Yang HC, D’Agati VD, Alpers CE, Fogo AB. Parietal epithelial cell activation marker in early recurrence of FSGS in the transplant. Clin J Am Soc Nephrol 7: 1852–1858, 2012. doi:10.2215/CJN.10571011.
    Crossref | PubMed | ISI | Google Scholar
  • 13. Fogo AB. Causes and pathogenesis of focal segmental glomerulosclerosis. Nat Rev Nephrol 11: 76–87, 2015. doi:10.1038/nrneph.2014.216.
    Crossref | PubMed | ISI | Google Scholar
  • 14. Hayashi A, Okamoto T, Yamazaki T, Sato Y, Takahashi T, Ariga T. CD44-positive glomerular parietal epithelial cells in a mouse model of calcineurin inhibitors-induced nephrotoxicity. Nephron 142: 71–81, 2019. doi:10.1159/000497325.
    Crossref | PubMed | ISI | Google Scholar
  • 15. Hoshi S, Shu Y, Yoshida F, Inagaki T, Sonoda J, Watanabe T, Nomoto K, Nagata M. Podocyte injury promotes progressive nephropathy in zucker diabetic fatty rats. Lab Invest 82: 25–35, 2002. doi:10.1038/labinvest.3780392.
    Crossref | PubMed | ISI | Google Scholar
  • 16. Hughes CE, Nibbs RJB. A guide to chemokines and their receptors. FEBS J 285: 2944–2971, 2018. doi:10.1111/febs.14466.
    Crossref | PubMed | ISI | Google Scholar
  • 17. Jankauskas SS, Wong DWL, Bucala R, Djudjaj S, Boor P. Evolving complexity of MIF signaling. Cell Signal 57: 76–88, 2019. doi:10.1016/j.cellsig.2019.01.006.
    Crossref | PubMed | ISI | Google Scholar
  • 18. Kobayashi N, Ueno T, Ohashi K, Yamashita H, Takahashi Y, Sakamoto K, Manabe S, Hara S, Takashima Y, Dan T, Pastan I, Miyata T, Kurihara H, Matsusaka T, Reiser J, Nagata M. Podocyte injury-driven intracapillary plasminogen activator inhibitor type 1 accelerates podocyte loss via uPAR-mediated β1-integrin endocytosis. Am J Physiol Renal Physiol 308: F614–F626, 2015. doi:10.1152/ajprenal.00616.2014.
    Link | ISI | Google Scholar
  • 19. Kriz W, Hosser H, Hähnel B, Simons JL, Provoost AP. Development of vascular pole-associated glomerulosclerosis in the Fawn-hooded rat. J Am Soc Nephrol 9: 381–396, 1998.
    PubMed | ISI | Google Scholar
  • 20. Kriz W, Gretz N, Lemley KV. Progression of glomerular diseases: is the podocyte the culprit? Kidney Int 54: 687–697, 1998. doi:10.1046/j.1523-1755.1998.00044.x.
    Crossref | PubMed | ISI | Google Scholar
  • 21. Lennon R, Hosawi S. Glomerular cell crosstalk. Curr Opin Nephrol Hypertens 25: 187–193, 2016. doi:10.1097/MNH.0000000000000221.
    Crossref | PubMed | ISI | Google Scholar
  • 22. Liu XQ, Fourel L, Dalonneau F, Sadir R, Leal S, Lortat-Jacob H, Weidenhaupt M, Albiges-Rizo C, Picart C. Biomaterial-enabled delivery of SDF-1α at the ventral side of breast cancer cells reveals a crosstalk between cell receptors to promote the invasive phenotype. Biomaterials 127: 61–74, 2017. doi:10.1016/j.biomaterials.2017.02.035.
    Crossref | PubMed | ISI | Google Scholar
  • 23. Mackay CR. Chemokines: immunology’s high impact factors. Nat Immunol 2: 95–101, 2001. doi:10.1038/84298.
    Crossref | PubMed | ISI | Google Scholar
  • 24. Matsusaka T, Xin J, Niwa S, Kobayashi K, Akatsuka A, Hashizume H, Wang QC, Pastan I, Fogo AB, Ichikawa I. Genetic engineering of glomerular sclerosis in the mouse via control of onset and severity of podocyte-specific injury. J Am Soc Nephrol 16: 1013–1023, 2005. doi:10.1681/ASN.2004080720.
    Crossref | PubMed | ISI | Google Scholar
  • 25. Nagata M, Kriz W. Glomerular damage after uninephrectomy in young rats. II. Mechanical stress on podocytes as a pathway to sclerosis. Kidney Int 42: 148–160, 1992. doi:10.1038/ki.1992.272.
    Crossref | PubMed | ISI | Google Scholar
  • 26. Nagata M, Nakayama K, Terada Y, Hoshi S, Watanabe T. Cell cycle regulation and differentiation in the human podocyte lineage. Am J Pathol 153: 1511–1520, 1998. doi:10.1016/S0002-9440(10)65739-2.
    Crossref | PubMed | ISI | Google Scholar
  • 27. Nagata M. Podocyte injury and its consequences. Kidney Int 89: 1221–1230, 2016. doi:10.1016/j.kint.2016.01.012.
    Crossref | PubMed | ISI | Google Scholar
  • 28. Nagata M, Kobayashi N, Hara S. Focal segmental glomerulosclerosis; why does it occur segmentally? Pflugers Arch 469: 983–988, 2017. doi:10.1007/s00424-017-2023-x.
    Crossref | PubMed | ISI | Google Scholar
  • 29. Ohse T, Pippin JW, Vaughan MR, Brinkkoetter PT, Krofft RD, Shankland SJ. Establishment of conditionally immortalized mouse glomerular parietal epithelial cells in culture. J Am Soc Nephrol 19: 1879–1890, 2008. doi:10.1681/ASN.2007101087.
    Crossref | PubMed | ISI | Google Scholar
  • 30. Okamoto T, Sasaki S, Yamazaki T, Sato Y, Ito H, Ariga T. Prevalence of CD44-positive glomerular parietal epithelial cells reflects podocyte injury in adriamycin nephropathy. Nephron, Exp Nephrol 124: 11–18, 2013. doi:10.1159/000357356.
    Crossref | PubMed | Google Scholar
  • 31. Pawig L, Klasen C, Weber C, Bernhagen J, Noels H. Diversity and inter-connections in the CXCR4 chemokine receptor/ligand family: molecular perspectives. Front Immunol 6: 429, 2015. doi:10.3389/fimmu.2015.00429.
    Crossref | PubMed | ISI | Google Scholar
  • 32. Rizzo P, Perico N, Gagliardini E, Novelli R, Alison MR, Remuzzi G, Benigni A. Nature and mediators of parietal epithelial cell activation in glomerulonephritides of human and rat. Am J Pathol 183: 1769–1778, 2013. doi:10.1016/j.ajpath.2013.08.008.
    Crossref | PubMed | ISI | Google Scholar
  • 33. Roeder SS, Barnes TJ, Lee JS, Kato I, Eng DG, Kaverina NV, Sunseri MW, Daniel C, Amann K, Pippin JW, Shankland SJ. Activated ERK1/2 increases CD44 in glomerular parietal epithelial cells leading to matrix expansion. Kidney Int 91: 896–913, 2017. doi:10.1016/j.kint.2016.10.015.
    Crossref | PubMed | ISI | Google Scholar
  • 34. Romoli S, Angelotti ML, Antonelli G, Kumar Vr S, Mulay SR, Desai J, Anguiano Gomez L, Thomasova D, Eulberg D, Klussmann S, Melica ME, Conte C, Lombardi D, Lasagni L, Anders HJ, Romagnani P. CXCL12 blockade preferentially regenerates lost podocytes in cortical nephrons by targeting an intrinsic podocyte-progenitor feedback mechanism. Kidney Int 94: 1111–1126, 2018. doi:10.1016/j.kint.2018.08.013.
    Crossref | PubMed | ISI | Google Scholar
  • 35. Rosenberg AZ, Kopp JB. Focal segmental glomerulosclerosis. Clin J Am Soc Nephrol 12: 502–517, 2017. doi:10.2215/CJN.05960616.
    Crossref | PubMed | ISI | Google Scholar
  • 36. Sakamoto K, Ueno T, Kobayashi N, Hara S, Takashima Y, Pastan I, Matsusaka T, Nagata M. The direction and role of phenotypic transition between podocytes and parietal epithelial cells in focal segmental glomerulosclerosis. Am J Physiol Renal Physiol 306: F98–F104, 2014. doi:10.1152/ajprenal.00228.2013.
    Link | ISI | Google Scholar
  • 37. Sasaki S, Nishihira J, Ishibashi T, Yamasaki Y, Obikane K, Echigoya M, Sado Y, Ninomiya Y, Kobayashi K. Transgene of MIF induces podocyte injury and progressive mesangial sclerosis in the mouse kidney. Kidney Int 65: 469–481, 2004. doi:10.1111/j.1523-1755.2004.00394.x.
    Crossref | PubMed | ISI | Google Scholar
  • 38. Shi X, Leng L, Wang T, Wang W, Du X, Li J, McDonald C, Chen Z, Murphy JW, Lolis E, Noble P, Knudson W, Bucala R. CD44 is the signaling component of the macrophage migration inhibitory factor-CD74 receptor complex. Immunity 25: 595–606, 2006. doi:10.1016/j.immuni.2006.08.020.
    Crossref | PubMed | ISI | Google Scholar
  • 39. Smeets B, Kuppe C, Sicking EM, Fuss A, Jirak P, van Kuppevelt TH, Endlich K, Wetzels JF, Gröne HJ, Floege J, Moeller MJ. Parietal epithelial cells participate in the formation of sclerotic lesions in focal segmental glomerulosclerosis. J Am Soc Nephrol 22: 1262–1274, 2011. doi:10.1681/ASN.2010090970.
    Crossref | PubMed | ISI | Google Scholar
  • 40. Smeets B, Stucker F, Wetzels J, Brocheriou I, Ronco P, Gröne HJ, D’Agati V, Fogo AB, van Kuppevelt TH, Fischer HP, Boor P, Floege J, Ostendorf T, Moeller MJ. Detection of activated parietal epithelial cells on the glomerular tuft distinguishes early focal segmental glomerulosclerosis from minimal change disease. Am J Pathol 184: 3239–3248, 2014. doi:10.1016/j.ajpath.2014.08.007.
    Crossref | PubMed | ISI | Google Scholar
  • 41. Sayyed SG, Hägele H, Kulkarni OP, Endlich K, Segerer S, Eulberg D, Klussmann S, Anders HJ. Podocytes produce homeostatic chemokine stromal cell-derived factor-1/CXCL12, which contributes to glomerulosclerosis, podocyte loss and albuminuria in a mouse model of type 2 diabetes. Diabetologia 52: 2445–2454, 2009. doi:10.1007/s00125-009-1493-6.
    Crossref | PubMed | ISI | Google Scholar
  • 42. Suzuki T, Matsusaka T, Nakayama M, Asano T, Watanabe T, Ichikawa I, Nagata M. Genetic podocyte lineage reveals progressive podocytopenia with parietal cell hyperplasia in a murine model of cellular/collapsing focal segmental glomerulosclerosis. Am J Pathol 174: 1675–1682, 2009. doi:10.2353/ajpath.2009.080789.
    Crossref | PubMed | ISI | Google Scholar
  • 43. Takashima S, Fujita H, Fujishima H, Shimizu T, Sato T, Morii T, Tsukiyama K, Narita T, Takahashi T, Drucker DJ, Seino Y, Yamada Y. Stromal cell-derived factor-1 is upregulated by dipeptidyl peptidase-4 inhibition and has protective roles in progressive diabetic nephropathy. Kidney Int 90: 783–796, 2016. doi:10.1016/j.kint.2016.06.012.
    Crossref | PubMed | ISI | Google Scholar
  • 44. Ueno T, Kobayashi N, Nakayama M, Takashima Y, Ohse T, Pastan I, Pippin JW, Shankland SJ, Uesugi N, Matsusaka T, Nagata M. Aberrant Notch1-dependent effects on glomerular parietal epithelial cells promotes collapsing focal segmental glomerulosclerosis with progressive podocyte loss. Kidney Int 83: 1065–1075, 2013. doi:10.1038/ki.2013.48.
    Crossref | PubMed | ISI | Google Scholar
  • 45. Waters AM, Wu MY, Onay T, Scutaru J, Liu J, Lobe CG, Quaggin SE, Piscione TD. Ectopic notch activation in developing podocytes causes glomerulosclerosis. J Am Soc Nephrol 19: 1139–1157, 2008. doi:10.1681/ASN.2007050596.
    Crossref | PubMed | ISI | Google Scholar
  • 46. Wharram BL, Goyal M, Wiggins JE, Sanden SK, Hussain S, Filipiak WE, Saunders TL, Dysko RC, Kohno K, Holzman LB, Wiggins RC. Podocyte depletion causes glomerulosclerosis: diphtheria toxin-induced podocyte depletion in rats expressing human diphtheria toxin receptor transgene. J Am Soc Nephrol 16: 2941–2952, 2005. doi:10.1681/ASN.2005010055.
    Crossref | PubMed | ISI | Google Scholar
  • 47. Yamazaki T, Sasaki S, Okamoto T, Sato Y, Hayashi A, Ariga T. Up-regulation of CD74 expression in parietal epithelial cells in a mouse model of focal segmental glomerulosclerosis. Nephron 134: 238–252, 2016. doi:10.1159/000448221.
    Crossref | PubMed | ISI | Google Scholar
  • 48. Yoo SA, Leng L, Kim BJ, Du X, Tilstam PV, Kim KH, Kong JS, Yoon HJ, Liu A, Wang T, Song Y, Sauler M, Bernhagen J, Ritchlin CT, Lee P, Cho CS, Kim WU, Bucala R. MIF allele-dependent regulation of the MIF coreceptor CD44 and role in rheumatoid arthritis. Proc Natl Acad Sci USA 113: E7917–E7926, 2016. doi:10.1073/pnas.1612717113.
    Crossref | PubMed | ISI | Google Scholar
Previous
Back to Top
Next